Description
An inhibitor of Eg5 (IC50 = 200 nM in an ATPase assay); selective for Eg5 over other kinesin subfamilies from four different organisms; induces accumulation of HeLa cells in the G2/M phase (75% at a concentration of 1 μM); inhibits spindle formation and induces radial arrangement of chromosomes in Xenopus oocytes; inhibits migration and growth of PANC-1 pancreatic cancer cells in a concentration-dependent manner; inhibits angiogenesis and induces severe circulation defects in zebrafish embryos
Formal name: 2,3,4,6,7,8-hexahydro-4-(3-hydroxyphenyl)-7,7-dimethyl-2-thioxo-5(1H)-quinazolinone
Synonyms:
Molecular weight: 302.4
CAS: 863774-58-7
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Cancer|Cell Cycle|G2/M||Research Area|Cancer|Cell Migration & Metastasis